MYL9 Recombinant Rabbit Monoclonal Antibody [PSH02-07]
Overview
Product Name
MYL9 Recombinant Rabbit Monoclonal Antibody [PSH02-07]
Antibody Type
Recombinant Rabbit monoclonal Antibody
Immunogen
Recombinant protein within human MYL9 aa 1-172 / 172.
Species Reactivity
Human, Mouse, Rat
Validated Applications
WB, FC
Molecular Weight
Predicted band size: 20 kDa
Positive Control
Jurkat cell lysate, MDA-MB-231 cell lysate, NIH/3T3 cell lysate, C2C12 cell lysate, C6 cell lysate, A431.
Conjugation
unconjugated
Clone Number
PSH02-07
RRID
Reactivity Data
| WB | FC | |
|---|---|---|
| Human |
|
|
| Mouse |
|
|
| Rat |
|
|
Product Features
Form
Liquid
Concentration
Storage Instructions
Shipped at 4℃. Store at +4℃ short term (1-2 weeks). Store at -20℃ long term.
Storage Buffer
PBS (pH7.4), 0.1% BSA, 40% Glycerol. Preservative: 0.05% Sodium Azide.
Isotype
IgG
Purification Method
Protein A affinity purified.
Application Dilution
-
WB
-
1:1,000
-
FC
-
1:1,000
Target
Function
Myosin, a structural component of muscle, consists of two heavy chains and four light chains. The protein encoded by this gene is a myosin light chain that may regulate muscle contraction by modulating the ATPase activity of myosin heads. The encoded protein binds calcium and is activated by myosin light chain kinase. Two transcript variants encoding different isoforms have been found for this gene.
Background References
1. Matsushita K et al. Clinicopathological significance of MYL9 expression in pancreatic ductal adenocarcinoma. Cancer Rep (Hoboken). 2022 Oct
2. Fournier N et al. Smooth muscle motility disorder phenotypes: A systematic review of cases associated with seven pathogenic genes (ACTG2, MYH11, FLNA, MYLK, RAD21, MYL9 and LMOD1). Intractable Rare Dis Res. 2022 Aug
Subcellular Location
Cytoplasm, cytoskeleton, cell cortex.
Synonyms
20 kDa myosin light chain antibody
Human 20kDa myosin light chain (MLC2) mRNA complete cds antibody
LC20 antibody
MGC3505 antibody
MLC 2 antibody
MLC-2C antibody
MLC2 antibody
MLY 9 antibody
MRLC1 antibody
MYL9 antibody
ExpandImages
-
Western blot analysis of MYL9 on different lysates with Rabbit anti-MYL9 antibody (HA721766) at 1/1,000 dilution.
Lane 1: Jurkat cell lysate (20 µg/Lane)
Lane 2: MDA-MB-231 cell lysate (20 µg/Lane)
Lane 3: NIH/3T3 cell lysate (20 µg/Lane)
Lane 4: C2C12 cell lysate (20 µg/Lane)
Lane 5: C6 cell lysate (20 µg/Lane)
Predicted band size: 20 kDa
Observed band size: 18 kDa
Exposure time: 2 minutes 45 seconds;
4-20% SDS-PAGE gel.
Proteins were transferred to a PVDF membrane and blocked with 5% NFDM/TBST for 1 hour at room temperature. The primary antibody (HA721766) at 1/1,000 dilution was used in 5% NFDM/TBST at 4℃ overnight. Goat Anti-Rabbit IgG - HRP Secondary Antibody (HA1001) at 1/50,000 dilution was used for 1 hour at room temperature. -
Flow cytometric analysis of A431 cells labeling MYL9.
Cells were fixed and permeabilized. Then stained with the primary antibody (HA721766, 1μg/mL) (red) compared with Rabbit IgG Isotype Control (green). After incubation of the primary antibody at +4℃ for an hour, the cells were stained with a iFluor™ 488 conjugate-Goat anti-Rabbit IgG Secondary antibody (HA1121) at 1/1,000 dilution for 30 minutes at +4℃. Unlabelled sample was used as a control (cells without incubation with primary antibody; black).
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"
Citation
-
Thrombin-mediated increased permeability of blood-brain barrier in diquat poisoning: Mechanistic insights and potential therapeutic targets
Journal: Ecotoxicology And Environmental Safety
DOI: 10.1016/j.ecoenv.2026.120087
IF: 6.1
Application: WB
Reactivity: Rat,Human
Publish date: 2026 Apr
Products with the same target and pathway
MYL9 Recombinant Rabbit Monoclonal Antibody [PSH02-07] - BSA and Azide free
Application: WB,FC
Reactivity: Human,Mouse,Rat
Conjugate: unconjugated
